Rapid bone regeneration by Escherichia coli-derived recombinant human bone morphogenetic protein-2 loaded on a hydroxyapatite carrier in the rabbit calvarial defect model

被引：14

作者：

Chung C.-H. ^{[1
]}

Kim Y.-K. ^{[1
]}

Lee J.-S. ^{[1
]}

Jung U.-W. ^{[1
]}

Pang E.-K. ^{[2
]}

Choi S.-H. ^{[1
]}

机构：

[1] Department of Periodontology, College of Dentistry, Yonsei University, 50 Yonsei-ro Seodaemun-gu, Seoul

[2] Department of Periodontology, School of Medicine, Ewha Womans University, Seoul

来源：

Biomaterials Research | / 19卷 / 1期

关键词：

Bone regeneration; Calvarial intraosseous defect model; Escherichia coli-derived recombinant human bone; Hydroxyapatite; Morphogenetic protein-2; Tissue engineering;

D O I：

10.1186/s40824-015-0039-x

中图分类号：

学科分类号：

摘要：

Background: The aim of this study was to determine the osteoconductivity of hydroxyapatite particles (HAP) as a carrier for Escherichia coli-derived recombinant human bone morphogenetic protein-2 (ErhBMP-2). Two 8-mm diameter bicortical calvarial defects were created in each of 20 rabbits. One of each pair of defects was randomly assigned to be filled with HAP only (HAP group) or ErhBMP-2 loaded HAP (ErhBMP-2/HAP group), while the other defect was left untreated (control group). The animals were killed after either 2 weeks (n = 10) or 8 weeks (n = 10) of healing, and histological, histomorphometric, and tomographic analyses were performed. Results: All experimental sites showed uneventful healing during the postoperative healing period. In both histomorphometric and tomographic analyses, the new bone area or volume of the ErhBMP-2/HAP group was significantly greater than that of the HAP and control groups at 2 weeks (p < 0.05). However, at 8 weeks, no significant difference in new bone area or volume was observed between the ErhBMP-2/HAP and HAP groups. The total augmented area or volume was not significantly different between the ErhBMP-2/HAP and HAP groups at 2 and 8 weeks. Conclusions: Combining ErhBMP-2 with HAP could significantly promote rapid initial new bone formation. Moreover, HAP graft could increase new bone formation and space maintenance, therefore it might be one of the effective carriers of ErhBMP-2. © 2015 Chung et al.

引用

共 34 条

[1]

Ebara S., Nakayama K., Mechanism for the action of bone morphogenetic proteins and regulation of their activity, Spine., 27, pp. S10-S15, (2002)

[2]

Hogan B.L., Bone morphogenetic proteins: multifunctional regulators of vertebrate development, Genes Dev., 10, pp. 1580-1594, (1996)

[3]

Wozney J.M., Overview of bone morphogenetic proteins, Spine., 27, pp. S2-8, (2002)

[4]

Herford A.S., Boyne P.J., Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2), J Oral Maxillofac Surg., 66, pp. 616-624, (2008)

[5]

Lan J., Wang Z.F., Shi B., Xia H.B., Cheng X.R., The influence of recombinant human BMP-2 on bone-implant osseointegration: biomechanical testing and histomorphometric analysis, Int J Oral Maxillofac Surg., 36, pp. 345-349, (2007)

[6]

Ono M., Sonoyama W., Yamamoto K., Oida Y., Akiyama K., Shinkawa S., Et al., Efficient bone formation in a swine socket lift model using Escherichia coli-derived recombinant human bone morphogenetic protein-2 adsorbed in beta-tricalcium phosphate, Cells Tissues Organs., 199, pp. 249-255, (2014)

[7]

Bessho K., Konishi Y., Kaihara S., Fujimura K., Okubo Y., Iizuka T., Bone induction by Escherichia coli-derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2, Br J Oral Maxillofac Surg., 38, pp. 645-649, (2000)

[8]

Choi Y., Yun J.H., Kim C.S., Choi S.H., Chai J.K., Jung U.W., Sinus augmentation using absorbable collagen sponge loaded with Escherichia coli-expressed recombinant human bone morphogenetic protein 2 in a standardized rabbit sinus model: a radiographic and histologic analysis, Clin Oral Implants Res., 23, pp. 682-689, (2012)

[9]

Lee J.K., Cho L.R., Um H.S., Chang B.S., Cho K.S., Bone formation and remodeling of three different dental implant surfaces with Escherichia coli-derived recombinant human bone morphogenetic protein 2 in a rabbit model, Int J Oral Maxillofac Implants., 28, pp. 424-430, (2013)

[10]

Hong S.J., Kim C.S., Han D.K., Cho I.H., Jung U.W., Choi S.H., Et al., The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects, Biomaterials., 27, pp. 3810-3816, (2006)

← 1 2 3 4 →